@elprofedepiano_ Y pedir permiso que tiene que ver con ser o no ser รฉticos? Vaya ni es falta a la moral. Cuando ella les cancele o cambie clase respondandale igual.๐คฃ
An enzyme named DGK-zeta is critical for the production of antibodies and the formation of memory B cells, according to new @SciSignal work in vitro and in vivo that suggests the enzyme serves as a linchpin of the #Bcell immune response. https://t.co/tYBcGB9LxU
The history and future of cancer immunotherapy is being discussed at a panel at #BIO2026 , and agonistic antbody immunotherapies have been highlighted - here's a comprehensive review on realizing their potential
https://t.co/Qp8iL1lxOS
https://t.co/R7ziJsHD9y
The PI3K/AKT/mTOR pathway has been a popular therapeutic target for cancer, immune regulation and genetic disorders. This Perspective in the June issue discusses challenges, lessons learned and new efforts in targeting this pathway
https://t.co/V83ZsoAVW1
https://t.co/FaUtZtkTQr
Memory regulatory T cells can shed their suppressive identity and become T follicular helper-like effector cells during recurrent malaria
https://t.co/lzMI7rD5ts @CTEGD@universityofga@NatImmunol
https://t.co/eun3OZHKqg
Hundreds of scientists who study cancer and aging have made an easily avoidable but significant mistake, deploying the wrong antibody to test for a key protein, according to a researcher who exposes errors in the biomedical literature.
Learn more: https://t.co/VsdVvOgrUo @NewsfromScience
ยฟHas tenido problemas porque un mismo panel ofrece resultados distintos en diferentes citรณmetros? Ve el webinar: ยฟ๐๐จ๐ซ ๐ช๐ฎ๐ฬ ๐ฎ๐ง ๐ฉ๐๐ง๐๐ฅ ๐ง๐จ ๐ฌ๐ ๐ฏ๐ ๐ข๐ ๐ฎ๐๐ฅ ๐๐ง ๐๐ข๐ฌ๐ญ๐ข๐ง๐ญ๐จ๐ฌ ๐๐ข๐ญ๐จฬ๐ฆ๐๐ญ๐ซ๐จ๐ฌ?
https://t.co/2rdZrRjnEV
#ASIleucemia#Citometrรญadeflujo
Te invitamos a ver la grabaciรณn del ๐๐๐๐ข๐ง๐๐ซ: ๐๐ฌ๐ญ๐ซ๐๐ญ๐๐ ๐ข๐๐ฌ ๐ฒ ๐ซ๐๐๐จ๐ฆ๐๐ง๐๐๐๐ข๐จ๐ง๐๐ฌ ๐ฉ๐๐ซ๐ ๐๐ฅ ๐๐ข๐ฌ๐๐งฬ๐จ ๐๐ ๐ฉ๐๐ง๐๐ฅ๐๐ฌ, con el ๐๐ซ. ๐๐ฎ๐๐ง ๐๐ฅ๐๐ฃ๐๐ง๐๐ซ๐จ ๐ ๐ฅ๐จ๐ซ๐๐ฌ ๐๐จ๐ง๐ญ๐๐ซ๐จ: https://t.co/z0vsqvEDd6 #EuroFlow#ASIleucemia